Intas enters into exclusive licence agreement with Syna to commercialise LB-0702 in gobal markets
Syna will develop and manufacture LB-0702 and supply the product to Intas and its worldwide affiliates
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Intas
Intas launches Romiplostim in India
With this, the drug firm makes therapy for chronic immune thrombocytopenia (ITP) more accessible to patients